REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
26/03/2021 15:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210326:nBw26KfQJa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 25 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,750,375 1.36% 189,823 0.15%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,859,410 1.44% 202,989 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 15 225.1700 USD
Purchase 31 222.6393 USD
Purchase 32 224.5050 USD
Purchase 46 224.3632 USD
Purchase 50 224.3900 USD
Purchase 69 223.8456 USD
Purchase 116 223.5129 USD
Purchase 120 224.1400 USD
Purchase 141 223.9708 USD
Purchase 224 223.2180 USD
Purchase 274 223.4471 USD
Purchase 354 224.2946 USD
Purchase 644 223.2246 USD
Purchase 666 223.9419 USD
Purchase 1,689 223.2568 USD
Purchase 1,994 223.4772 USD
Purchase 2,452 224.5000 USD
Purchase 2,941 224.4995 USD
Purchase 3,329 223.8667 USD
Purchase 4,893 224.2041 USD
Purchase 5,341 224.4856 USD
Purchase 5,831 223.5647 USD
Purchase 6,293 223.6108 USD
Purchase 16,629 223.5146 USD
Purchase 23,589 224.1750 USD
Sale 2 223.6950 USD
Sale 15 224.2400 USD
Sale 31 223.8800 USD
Sale 100 223.8400 USD
Sale 100 224.7100 USD
Sale 117 224.5858 USD
Sale 129 224.3317 USD
Sale 160 223.3871 USD
Sale 200 223.5800 USD
Sale 300 222.6866 USD
Sale 300 224.3200 USD
Sale 300 224.1600 USD
Sale 300 223.7100 USD
Sale 320 223.8190 USD
Sale 400 223.0775 USD
Sale 461 223.9125 USD
Sale 500 223.4590 USD
Sale 500 223.2180 USD
Sale 500 222.8310 USD
Sale 801 224.1668 USD
Sale 900 223.5116 USD
Sale 1,089 223.2889 USD
Sale 1,201 223.2566 USD
Sale 2,514 224.0712 USD
Sale 3,147 223.3418 USD
Sale 3,190 223.8723 USD
Sale 4,593 224.1966 USD
Sale 4,841 224.4978 USD
Sale 4,950 223.4838 USD
Sale 5,948 224.5000 USD
Sale 6,952 223.6220 USD
Sale 9,484 224.1224 USD
Sale 11,548 223.6114 USD
Sale 12,604 224.2232 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 26 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210326005328/en/
(https://www.businesswire.com/news/home/20210326005328/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Entain PLC Barclays PLC - TR1: Notification of Major Holdings
AnnouncementREG - Gym Group PLC (The) Barclays PLC - Holding(s) in Company
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement